Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England
Author:
Publisher
Elsevier BV
Subject
Health Policy,Medicine (miscellaneous)
Reference53 articles.
1. The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era;Amram;American Journal of Drug and Alcohol Abuse,2021
2. Availability and use of non-prescribed buprenorphine-naloxone in a Canadian setting 2014-2020;Bach;International Journal of Drug Policy,2022
3. Did drug use increase following COVID-19 relaxation of methadone take-out regulations ? 2020 was a complicated year;Bart;Journal of Substance Abuse Treatment,2022
4. Disposition of toxic drugs and chemicals in man;Baselt,2011
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Buprenorphine deaths confirmed by toxicology reveal a low proportion of opioid agonist treatment before death in Finland;International Journal of Legal Medicine;2024-06-24
2. Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review;International Journal of Drug Policy;2024-05
3. Letter from America: A British addiction psychiatrist's experience of opioid agonist treatment in the United States;Journal of Substance Use and Addiction Treatment;2024-03
4. Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis;Drug and Alcohol Dependence;2024-03
5. Understanding and learning from rural drug service adaptations to opioid substitution therapy during the COVID-19 pandemic: the What C-OST? study;Frontiers in Public Health;2023-11-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3